MedAssets Goes Red
Feb 20th 2013 9:50PM
Updated Feb 20th 2013 9:55PM
MedAssets (NAS: MDAS) reported earnings on Feb. 20. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), MedAssets beat expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share dropped significantly. GAAP earnings per share contracted to a loss.
Margins dropped across the board.
MedAssets logged revenue of $163.8 million. The 15 analysts polled by S&P Capital IQ expected revenue of $159.8 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.27. The 15 earnings estimates compiled by S&P Capital IQ anticipated $0.28 per share. Non-GAAP EPS of $0.27 for Q4 were 16% lower than the prior-year quarter's $0.32 per share. GAAP EPS were -$0.25 for Q4 compared to $0.07 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 76.8%, 330 basis points worse than the prior-year quarter. Operating margin was 15.6%, 40 basis points worse than the prior-year quarter. Net margin was -8.8%, 1,140 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $160.5 million. On the bottom line, the average EPS estimate is $0.28.
Next year's average estimate for revenue is $677.7 million. The average EPS estimate is $1.28.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 64 members out of 76 rating the stock outperform, and 12 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 23 give MedAssets a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MedAssets is outperform, with an average price target of $20.00.
Is MedAssets the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add MedAssets to My Watchlist.
The article MedAssets Goes Red originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.